Intellectual Property

  • June 08, 2026

    ITC Probing Amazon Smart Devices For AI Patent Infringement

    The U.S. International Trade Commission will investigate claims by artificial intelligence company Cerence AI that Amazon's smart devices infringe a collection of patents and thus should be subject to a limited exclusion order.

  • June 08, 2026

    Roche To Pay Nurix Up To $2.3B In Cancer Drug Deal

    Swiss healthcare giant Roche said Monday that it will pay U.S. biopharmaceutical company Nurix up to $2.3 billion to codevelop and sell a therapy being developed to treat certain cancers and autoimmune diseases through targeted protein degradation.

  • June 05, 2026

    Fed. Circ. Asks If Co. Argued Capability Equals Infringement

    The Federal Circuit appeared to have doubts Friday morning about patent-licensing outfit PACT XPP Schweiz's position it had argued below that an Intel product could violate its patent even if it never performed an infringing action but was capable of doing so.

  • June 05, 2026

    Streamer's 'Lazy Reaction' Video May Be Fair Use, Judge Says

    A California federal judge said Friday he is inclined to toss a YouTube creator's copyright suit over a Twitch user's livestreamed response to a documentary, finding that what the plaintiff characterized as "lazy reaction" content that siphoned views from the original work is covered by fair use because of the defendant's real-time criticism, commentary and mockery.

  • June 05, 2026

    Chinese Co. Barred From Claiming Connection To Olympics

    A Chinese company and affiliates were blocked by a California federal court judge from using trademarks associated with the Olympics or claiming to have any affiliation with the games, after the International Olympic Committee claimed they were falsely using marks to sell products with purported health benefits.

  • June 05, 2026

    Fed. Circ. Unsure Where State 'Bad Faith' Patent Cases Belong

    At arguments Friday in a dispute between Micron Technology Inc. and Netlist Inc., a Federal Circuit panel appeared uncertain whether suits under state laws against "bad faith" patent infringement claims belong in state or federal courts, analyzing the impact on patent law of each approach.

  • June 05, 2026

    Fed. Circ. Thinking About EcoFactor In TP-Link's $38M Appeal

    A Federal Circuit panel on Friday seemed skeptical of a challenge by a pair of wireless networking device companies to the damages calculation supporting a $37.5 million patent infringement verdict against them, with one judge wondering if the court's EcoFactor decision did not "clean up" the issue of damages experts.

  • June 05, 2026

    Musicians Say UMG, Warner Stiffed Them On AI Licensing

    The American Federation of Musicians of the United States and Canada claims Universal Music Group and Warner Music Group violated its members' collective bargaining agreement by licensing sound recordings to two artificial intelligence companies without compensating the musicians involved, according to a lawsuit filed Friday in New York federal court.

  • June 05, 2026

    GOP Lawmakers Target China With 2 Patent Bills

    Republican lawmakers are floating a pair of bills that would block anyone who is considered a national security threat from gaining a U.S. patent and require anyone with connections to "foreign adversaries" to list the association on an application.

  • June 05, 2026

    Judge Rejects Objectors' Bid For More Equity In NIL Proposal

    A California federal magistrate judge has turned down a group of athletes' objection to a proposed addition to the $2.78 billion settlement with the NCAA that the group said would disproportionately benefit men in major revenue college sports.

  • June 05, 2026

    TelevisaUnivision Sues To Stop Pirated World Cup Streams

    TelevisaUnivision sued several online streaming services Thursday, asking a Florida federal court to shut down plans to pirate the Spanish-language media company's exclusive broadcasts of the upcoming FIFA World Cup.

  • June 05, 2026

    Fed. Circ. Backs Melinta Patent Win In Injections Case

    Nexus Pharmaceuticals lost its appeal of an Illinois federal judge's finding that it infringed a pair of patents relating to a line of injections that treat infections, after the Federal Circuit on Friday shot down the drugmaker's challenge to the lower court's interpretation of key patent terms.

  • June 05, 2026

    4th Circ. Upholds Sanctions For Late Copyright Damages Info

    The Fourth Circuit affirmed a ruling that excluded a software company's damages evidence and granted summary judgment to its competitor, saying in a published opinion Friday that the plaintiff's repeated failure to disclose its damages calculation justified sanctions that effectively doomed its copyright, false advertising and contract claims.

  • June 05, 2026

    Fed. Circ. OKs Google, Microsoft Win Over Device Locator IP

    The Federal Circuit on Friday rejected an inventor's attempt to revive claims in her computer-locating patents challenged by Google and Microsoft, backing the Patent Trial and Appeal Board's decisions that they were invalid.

  • June 05, 2026

    Judge Wants A Look At OnePlus-Pantech Deal In 5G SEP Suit

    A Texas federal judge told Chinese phone company OnePlus and its South Korean competitor Pantech Corp. to provide the court with the settlement agreement under which they want a case between them dismissed, after a jury awarded Pantech $1 million for patent infringement.

  • June 05, 2026

    Nortek Accuses Rival Of Stealing Data Center Cooling Secrets

    Ventilation company Nortek has hit a rival with allegations that, in response to the rising demand for cooling technology in data centers as a result of the artificial intelligence boom, it "raided" Nortek's employees and misappropriated trade secrets related to such technology.

  • June 05, 2026

    Will WDTX Remain A Patent Fixture Without Albright?

    Whether the Western District of Texas will continue drawing in hordes of patent cases after U.S. District Judge Alan Albright leaves this summer has attorneys torn, given that he's no longer the top patent judge in his district, let alone the country.

  • June 05, 2026

    ITC Opens Patent Probe Of Imported Pickleball Paddles

    The U.S. International Trade Commission announced it is opening an investigation into pickleball paddles made by Franklin Sports and 19 other companies that a Maryland manufacturer alleges violate two of its patents.

  • June 05, 2026

    DLA Piper Adds Ex-ArentFox Schiff Gov't Contracts Lawyer

    DLA Piper LLP has hired a former ArentFox Schiff LLP government contracts partner who throughout his career has advised on multimillion-dollar deals for corporate, private equity and other clients.

  • June 05, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the U.K.'s oldest Indian restaurant launch an appeal against King Charles III's property company in an effort to stop its eviction, trustees of a bankrupt former EY tax partner file a claim against his wife, and 37 leading insurers bring a lawsuit against agrichemical company Syngenta over an insurance dispute. Here, Law360 looks at these and other new claims in the U.K.

  • June 04, 2026

    Trump Era Worse Than McCarthy For Speech, Law Dean Says

    The dean of UC Berkeley's law school told an audience of lawyers and artists on Thursday that America is experiencing "an unprecedented assault on the Constitution, on the First Amendment, and on freedom of speech," comparing the country under President Donald Trump unfavorably to the McCarthy era.

  • June 04, 2026

    Generics Cos. Get More Freedom In High Court Patent Ruling

    The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid such suits and creates hurdles for branded companies pursuing infringement litigation, attorneys say.

  • June 04, 2026

    Amgen Won't Face 'Nonsensical' Rodent Antibody IP At Trial

    A Delaware federal judge has trimmed Harbour Medical's infringement suit against an Amgen unit just days before trial, saying two of the company's mouse antibody patents are indefinite based on a term that "everyone agrees" is "nonsensical."

  • June 04, 2026

    Ex-Football Stars Sue NCAA, Conferences For Lost NIL Pay

    Two college football stars, who went on to play in the NFL, have filed antitrust suits claiming the NCAA, Big Ten and Southeastern conferences exploited them for their abilities while denying them compensation for their names, images and likenesses.

  • June 04, 2026

    Eli Lilly's 'Overbroad' Weight Drug TM Deal Rejected

    A Washington federal judge has refused to sign off on a deal to settle trademark claims brought by Eli Lilly against two Seattle-area medical clinics, saying the associated consent decree was "overbroad" and contained an even more sweeping injunction.

Expert Analysis

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • Opinion

    Judges Carry Onus To Screen Expert Opinions Before Juries

    Author Photo

    Recent Second Circuit arguments in Acetaminophen Products Liability Litigation implied a low bar for judicial gatekeeping of expert testimony, but under amended Rule 702 of the Federal Rules of Evidence, judges must rigorously scrutinize expert opinions before allowing them to reach juries, says Lee Mickus at Evans Fears.

  • Labubu Highlights Evolving IP Strategies In Modern Markets

    Author Photo

    Pop Mart's decision not to pursue U.S. patents for its Labubu plush dolls — relying instead on expressive rights — is rational given the nature of the product and the velocity of the market, and also underscores broader structural issues that may hold the U.S. patent system from keeping pace with modern markets, says Tina Dorr at Barnes & Thornburg.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Opinion

    Justices Should Clarify Loper Bright Doctrine Via Patent Case

    Author Photo

    The U.S. Supreme Court should use the Lynk Labs v. Samsung patent case to provide urgently needed guidance on how last year’s Loper Bright decision should be applied to real-world questions of agency authority in the post-Chevron world, says Timothy Hsieh at Oklahoma City University School of Law.

  • 7 Strategies To Optimize Impact Of Direct Examination

    Author Photo

    Direct examination is a make-or-break opportunity to build a witness’s credibility, so attorneys should adopt a few tactics — from asking so-called trust-fall questions to preemptively addressing weaknesses — to drive impact and retention with the fact-finder, says Allison Rocker at Baker McKenzie.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Intellectual Property Challenges In AI-Driven Drug Discovery

    Author Photo

    Given the adoption of artificial intelligence-based drug discovery platforms and the U.S. Patent and Trademark Office's recent guidance on determining inventorship in AI-assisted inventions, practitioners must consider unprecedented questions regarding inventorship, patentability standards and infringement liability, says Paul Calvo at Sterne Kessler.

  • Software Patents May Face New Eligibility Scrutiny

    Author Photo

    November guidance from the U.S. Patent and Trademark Office, along with recent litigation trends from the Federal Circuit, may encourage new challenges in the USPTO and district courts to artificial intelligence and software patents that rely on generic computing functions without concrete details, say attorneys at Venable.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

  • Riding The Changing Winds For AI Innovations At The USPTO

    Author Photo

    As recent U.S. Patent and Trademark Office moves reshape how artificial intelligence inventions will be examined and put them on firmer eligibility footing, practitioners need to consider how this shift is both an opportunity and a challenge, say Ryan Phelan at Marshall Gerstein and attorney Mark Campagna.

  • Series

    The Law Firm Merger Diaries: Integrating Practice Groups

    Author Photo

    Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.

  • Tapping Into Jurors' Moral Intuitions At Trial

    Author Photo

    Many jurors approach trials with foundational beliefs about fairness, harm and responsibility that shape how they view evidence and arguments, so attorneys must understand how to frame a case in a way that appeals to this type of moral reasoning, says Steve Wood at Courtroom Sciences.

  • Patent Disclaimers Ruling Offers Restriction Practice Insights

    Author Photo

    The Federal Circuit's recent decision in Focus Products v. Kartri confirms that prosecution disclaimers can extend to examiner-defined species in restriction practice, making it important for patent practitioners to manage restriction requirement responses carefully to avoid unintended claim scope limitations, say attorneys at BCLP.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.